期刊文献+

Hedgehog信号通路在肾纤维化中的研究进展 被引量:7

Research progress of Hedgehog signaling pathway in renal fibrosis
下载PDF
导出
摘要 肾纤维化是大多数慢性肾脏病(CKD)的共同病理表现,也是导致终末期肾病的主要病理变化。近年研究发现,Hedgehog(Hh)信号通路在肾纤维化中起重要作用。此通路区别于以往研究较多的TGF-β及Wnt通路等,其激活主要直接靶向作用于肾纤维化发生的中心事件——肌成纤维细胞的活化、增殖与转化,暗示此通路在肾纤维化发生过程中起极为重要作用,而此通路与其他通路相互作用亦促进肾纤维化发生发展。深入对此通路的研究可能为治疗肾纤维化提供新思路。文章就Hh信号通路与肾纤维化的关系进行综述。 Renal fibrosis is a common pathological manifestation of most chronic kidney disease(CKD)and a major pathological change leading to end-stage renal disease.Recent studies have found that the Hedgehog(Hh)signaling pathway plays an important role in renal fibrosis.This pathway is different from the TGF-βand Wnt pathways that have been studied in the past.Its activation mainly directly targets the central event of renal fibrosis-activation,proliferation and transformation of myofibroblasts.It suggests that this pathway plays an important role in the process of renal fibrosis,and this pathway interacts with other pathways to promote the development of renal fibrosis.Further research into this pathway may provide new ideas for the treatment of renal fibrosis.This article reviews the relationship between Hh signaling pathway and renal fibrosis.
作者 李庆 李均 reviewing);LI Jun(checking)(The Zhuhai Campus of the Zunyi Medical University,Zhuhai 519000,Guangdong,China)
出处 《医学研究生学报》 CAS 北大核心 2019年第10期1089-1093,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(8166140205)
关键词 肾纤维化 慢性肾脏病 HEDGEHOG信号通路 肌成纤维细胞 renal fibrosis chronic kidney disease Hedgehog signaling pathway myofibroblast
  • 相关文献

参考文献3

二级参考文献24

  • 1Lee JH, Kim JH, Kim JS, et al. AMP-activated protein kinase inhibits TGF-I-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition [ J ]. Am J Physiol Renal Physiol, 2013, 304(6) : 686-697.
  • 2Axelsson J, Rippe A, Rippe B. Acute hyperglycemia induces rap- id, reversible increases in glomeralar permeability in nondiabetic rats[J]. Am J Physiol Renal Physiol, 2010, 298 (6): 1306- 1312.
  • 3Komers R, Oyama TT, Beard DR, et al. Effects of systemic in- hibition of Rho kinase on blood pressure and renal haemodynam- ics in diabetic rats[J]. Br J Pharmacol, 2011, 162(1 ) : 163- 174.
  • 4Kikuchi Y, Yamada M, Imakiire T, et al. A Rho-kinase inhibi- tor, fasudil, prevents development of diabetes and nepbropathy in insulin-resistant diabetic rats[ J]. J Endocrinol, 2007, 192(3) : 595 -603.
  • 5Gojo A, Utsunomiya K, Taniguchi K, et al. The Rho-kinase in- hibitor, fasudil, attenuates diabetic nephropathy in streptozoto- cin-induced diabetic rats [ J ]. Eur J Pharmacd, 2007, 568 (1) : 242 -247.
  • 6Kolavennu V, Zeng L, Peng H, et al. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy inde- pendent of glucose control [ J ]. Diabetes, 2008, 57 ( 3 ) : 714- 723.
  • 7Chen CL, Chou KJ, Lee PT, et al. Erythropoietin suppresses ep- ithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PKD cell lines[J]. Exp Cell Res, 2010, 316 (7) : 1109-1118.
  • 8Lin X, Jiang C, Luo Z, et al. Protective effect of Erythropoietin on renal injury induced in rats by four weeks of exhaustive exer- cise[J]. BMC Nephrol, 2013, 14: 130.
  • 9Navarro-Gonzalez JF, Mora-Fernandez C, de Fuentes MM, et al. Inflammatory molecules and pathways in the pathogenesis Of dia- betic nephropathy[ J ]. Nat Rev Nephrol, 2011, 7 (6) : 327- 340.
  • 10Nairz M, Sonnweber T, Schroll A, et al. The pleiotropic effects of erythropoietin in infection and inflammation[J]. Microbes In- fect, 2012, 14(3): 238-246.

共引文献16

同被引文献98

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部